BevacizumabGenomicTestingGeneMutationMethotrexateLumpAbsoluteRiskCheckpointInhibitorPathologicResponseLymphoscintigraphy1 in 8womenGeneticCounselingEstrogenDocetaxelGailModelER-BOCAFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.FamilyHistoryMegestrolAcetateSelf-examinationPhysicalactivity mayreduce therisk of breastcancersAxillarySamplingAngiogenesisIntraductalPapillomaTumorGradeCapecitabineCytotoxicBI-RADSMastodyniaPARPInhibitors5-FluorouracilFibroadenomaAyurvedaCMFChemotherapyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenDefinitiveSurgeryAromataseInhibitorsHormoneReceptorStatusDown-StagingGuaranteedRenewableInsuranceCAMNodePositiveWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.NodeNegativePalbociclibRadiotherapyMastectomyIn-situCarcinomaKappaEpsilonPaclitaxelKi-67RatePI3KinaseInhibitorsDimplingFISHBRCAGeneAdenocarcinomaAdvocacyBiopsyEstradiolCDK4/6InhibitorsBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55Mammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltRaloxifeneAntibodyTherapyCystTyrosine-KinaseInhibitorECOGScoreAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerGeneticPredispositionHerceptinOvarianSuppressionRADFlowCytometryMultifocalTumorsHER-2PagetDiseaseMRIEGFR(epidermalgrowth factorreceptor)ChemopreventionMetastasisCyclophosphamideAdjuvantTherapyStagingTamoxifenCachexiaSERMMorpheaDoseDenseTherapyLymphNodeStatusBreastCancerNeoplasmTripleNegativeBreastCancerER+TriplePositiveBreastCancerPalpationACChemotherapyMultimodalityTherapyPrecisionMedicineLCISDoxorubicinGermlineMutationImmunotherapyHormoneReplacementTherapyLapatinibInvasiveBreastCancerAntiemeticPhyllodesTumorApoptosisOligometastasesLumpectomyCalcificationsCytostaticBrachytherapymTORInhibitorsBreastTomosynthesisAlopeciaAnastrozoleWomen ages40+ shouldhave a clinicalbreast examat least yearlyEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearExcisionalBiopsyRelapseChemotherapyNeoadjuvantTherapyProgestinBilateralProphylacticMastectomyCo-survivorBevacizumabGenomicTestingGeneMutationMethotrexateLumpAbsoluteRiskCheckpointInhibitorPathologicResponseLymphoscintigraphy1 in 8womenGeneticCounselingEstrogenDocetaxelGailModelER-BOCAFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.FamilyHistoryMegestrolAcetateSelf-examinationPhysicalactivity mayreduce therisk of breastcancersAxillarySamplingAngiogenesisIntraductalPapillomaTumorGradeCapecitabineCytotoxicBI-RADSMastodyniaPARPInhibitors5-FluorouracilFibroadenomaAyurvedaCMFChemotherapyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenDefinitiveSurgeryAromataseInhibitorsHormoneReceptorStatusDown-StagingGuaranteedRenewableInsuranceCAMNodePositiveWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.NodeNegativePalbociclibRadiotherapyMastectomyIn-situCarcinomaKappaEpsilonPaclitaxelKi-67RatePI3KinaseInhibitorsDimplingFISHBRCAGeneAdenocarcinomaAdvocacyBiopsyEstradiolCDK4/6InhibitorsBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55Mammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltRaloxifeneAntibodyTherapyCystTyrosine-KinaseInhibitorECOGScoreAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerGeneticPredispositionHerceptinOvarianSuppressionRADFlowCytometryMultifocalTumorsHER-2PagetDiseaseMRIEGFR(epidermalgrowth factorreceptor)ChemopreventionMetastasisCyclophosphamideAdjuvantTherapyStagingTamoxifenCachexiaSERMMorpheaDoseDenseTherapyLymphNodeStatusBreastCancerNeoplasmTripleNegativeBreastCancerER+TriplePositiveBreastCancerPalpationACChemotherapyMultimodalityTherapyPrecisionMedicineLCISDoxorubicinGermlineMutationImmunotherapyHormoneReplacementTherapyLapatinibInvasiveBreastCancerAntiemeticPhyllodesTumorApoptosisOligometastasesLumpectomyCalcificationsCytostaticBrachytherapymTORInhibitorsBreastTomosynthesisAlopeciaAnastrozoleWomen ages40+ shouldhave a clinicalbreast examat least yearlyEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearExcisionalBiopsyRelapseChemotherapyNeoadjuvantTherapyProgestinBilateralProphylacticMastectomyCo-survivor

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. Bevacizumab
  2. Genomic Testing
  3. Gene Mutation
  4. Methotrexate
  5. Lump
  6. Absolute Risk
  7. Checkpoint Inhibitor
  8. Pathologic Response
  9. Lymphoscintigraphy
  10. 1 in 8 women
  11. Genetic Counseling
  12. Estrogen
  13. Docetaxel
  14. Gail Model
  15. ER-
  16. BOCA
  17. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  18. Family History
  19. Megestrol Acetate
  20. Self-examination
  21. Physical activity may reduce the risk of breast cancers
  22. Axillary Sampling
  23. Angiogenesis
  24. Intraductal Papilloma
  25. Tumor Grade
  26. Capecitabine
  27. Cytotoxic
  28. BI-RADS
  29. Mastodynia
  30. PARP Inhibitors
  31. 5-Fluorouracil
  32. Fibroadenoma
  33. Ayurveda
  34. CMF Chemotherapy
  35. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  36. Definitive Surgery
  37. Aromatase Inhibitors
  38. Hormone Receptor Status
  39. Down-Staging
  40. Guaranteed Renewable Insurance
  41. CAM
  42. Node Positive
  43. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  44. Node Negative
  45. Palbociclib
  46. Radiotherapy
  47. Mastectomy
  48. In-situ Carcinoma
  49. Kappa Epsilon
  50. Paclitaxel
  51. Ki-67 Rate
  52. PI3 Kinase Inhibitors
  53. Dimpling
  54. FISH
  55. BRCA Gene
  56. Adenocarcinoma
  57. Advocacy
  58. Biopsy
  59. Estradiol
  60. CDK4/6 Inhibitors
  61. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  62. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  63. Raloxifene
  64. Antibody Therapy
  65. Cyst
  66. Tyrosine-Kinase Inhibitor
  67. ECOG Score
  68. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  69. Genetic Predisposition
  70. Herceptin
  71. Ovarian Suppression
  72. RAD
  73. Flow Cytometry
  74. Multifocal Tumors
  75. HER-2
  76. Paget Disease
  77. MRI
  78. EGFR (epidermal growth factor receptor)
  79. Chemoprevention
  80. Metastasis
  81. Cyclophosphamide
  82. Adjuvant Therapy
  83. Staging
  84. Tamoxifen
  85. Cachexia
  86. SERM
  87. Morphea
  88. Dose Dense Therapy
  89. Lymph Node Status
  90. Breast Cancer
  91. Neoplasm
  92. Triple Negative Breast Cancer
  93. ER+
  94. Triple Positive Breast Cancer
  95. Palpation
  96. AC Chemotherapy
  97. Multimodality Therapy
  98. Precision Medicine
  99. LCIS
  100. Doxorubicin
  101. Germline Mutation
  102. Immunotherapy
  103. Hormone Replacement Therapy
  104. Lapatinib
  105. Invasive Breast Cancer
  106. Antiemetic
  107. Phyllodes Tumor
  108. Apoptosis
  109. Oligometastases
  110. Lumpectomy
  111. Calcifications
  112. Cytostatic
  113. Brachytherapy
  114. mTOR Inhibitors
  115. Breast Tomosynthesis
  116. Alopecia
  117. Anastrozole
  118. Women ages 40+ should have a clinical breast exam at least yearly
  119. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  120. Excisional Biopsy
  121. Relapse
  122. Chemotherapy
  123. Neoadjuvant Therapy
  124. Progestin
  125. Bilateral Prophylactic Mastectomy
  126. Co-survivor